ORIENT BIO Market Cap

ORIENT BIO has a market cap or net worth of 64.50 billion as of April 29, 2026. Its market cap has decreased by -74.99% in one year.

Market Cap

64.50B

Enterprise Value

n/a

Revenue

59.09B

Ranking

n/a

PE Ratio

n/a

Stock Price

544.00

Market Cap Chart

Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 64.50B, an increase of 106.73%. That is a compound annual growth rate of 2.40%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	65.33B	-8.32%
Dec 30, 2025	71.26B	-61.15%
Dec 30, 2024	183.42B	154.86%
Dec 28, 2023	71.97B	-0.98%
Dec 29, 2022	72.68B	-49.75%
Dec 30, 2021	144.65B	-3.55%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
GeneOne Life Science	91.67B
CG Invites	98.96B
IMB Dx	102.61B
Oncocross	107.32B
iNtRON Biotechnology	120.13B
Amicogen	131.18B
Xcell Therapeutics	29.31B
ENCell	176.61B

Market Cap Rankings